Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-07-21
2008-08-12
Tsang, Cecilia (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S311000, C424S009100
Reexamination Certificate
active
07410943
ABSTRACT:
The invention relates to compounds of formula (I): and their use as targeting vectors that bind to receptors associated with angiogenesis. Such compounds may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's sarcoma.
REFERENCES:
patent: 5888474 (1999-03-01), Lister-James et al.
patent: WO/1995/014714 (1995-06-01), None
patent: 01/77145 (2001-10-01), None
patent: 02/20610 (2002-03-01), None
patent: 02/062819 (2002-08-01), None
patent: 03/006491 (2003-01-01), None
Int'l Search Report dated Nov. 2004 for PCT/GB2004/003150.
Pearson, D.A. et al., “Thrombus Imaging Using Technetium-99M-Labeled High Potency GPIIB/IIIA Receptor Antagonists. Chemistry and Initial Biological Studies” Journal of Medicinal Chemistry, American Chemical society, Washington, US, vol. 39, No. 7, 1996 pp. 1372-1382.
Harris, T.D., et.al., “Tc-99m-labeled Fibrinogen Receptor Antagonists: Design and Synthesis of Cyclic RGD Peptides for the Detection of Thrombi” Bioorganic & Medicinal Chemistry Letters, Oxford, GB, vol. 6, No. 15, Aug. 1996 pp. 1741-1746.
Cuthbertson Alan
Solbakken Magne
Audet Maury
GE Healthcare AS
Tsang Cecilia
LandOfFree
Imaging agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imaging agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imaging agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4000619